CCAAT enhancer-binding protein alpha is required for interleukin-6 receptor alpha signaling in newborn hepatocytes. (Q51039740)

27 March 2018

title

CCAAT enhancer-binding protein alpha is required for interleukin-6 receptor alpha signaling in newborn hepatocytes. (English)

1 reference

27 March 2018

author name string

Stephanie L Mackey

series ordinal

1

1 reference

27 March 2018

Gretchen J Darlington

series ordinal

2

1 reference

27 March 2018

language of work or name

English

0 references

publication date

11 February 2004

1 reference

27 March 2018

Journal of Biological Chemistry

published in

1 reference

27 March 2018

volume

279

1 reference

27 March 2018

issue

16

1 reference

27 March 2018

page(s)

16206-16213

1 reference

27 March 2018

Cytokines and the hepatic acute phase response

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Characterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene Promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Regulation of rabbit alpha 1-acid glycoprotein gene expression in acute-phase liver. Identification of inducible and constitutive proteins like CCAAT-enhancer binding protein that interact with the 5'-proximal promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

C/EBPalpha is critical for the neonatal acute-phase response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Defective inflammatory response in interleukin 6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Impaired energy homeostasis in C/EBP alpha knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Gp130 and the interleukin-6 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

IMPAIRED STAT3 ACTIVATION FOLLOWING LOCALIZED INFLAMMATORY STIMULUS IN IL-6-DEFICIENT MICE

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

21 January 2018

The acute phase response

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

The hepatic interleukin-6 receptor Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

The function of the soluble IL-6 receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400737200

21 January 2018

Identifiers

DOI

10.1074/JBC.M400737200

1 reference

27 March 2018

1 reference

27 March 2018